SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QLT PhotoTherapeutics (QLTI)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1321 51 0 QLTI
Emcee:  Doug Lakin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1246Isn't the phrase "shareholders' rights" a misnomer? Isn't Elmer-3/12/2002
1245<b>QLT renews shareholder rights plan</b> Existing Rights Plan Al Collard-3/12/2002
12442:27 (Dow Jones) IMS Health (RX) reported that U.S. sales of QLT Inc.'s (QLTIan@SI-3/6/2002
124316:13 ET QLT Photother tops estimates; updates guidance (QLTI) 17.87 -1.38: RepoIan@SI-2/6/2002
1242Ian, OK, thanks, just coincidence, then. Still, not totally OT, if QLTI still tuck-11/13/2001
1241Tuck, If I remember correctly, a couple years ago, QLT sold Photophrin to AxcanIan@SI-11/13/2001
1240Oops! My mistake. I never looked into this aspect of the product's potentiThe Ox-11/13/2001
1239Michael, Excuse me? This is taken from the the subject post of this thread: &tuck-11/13/2001
1238You do realize that this has absolutely nothing to do with QLTI. The link you rThe Ox-11/13/2001
1237Fly in the ointment? Message 16574183 Nice dig, Wilder. Explains the recent ctuck-11/13/2001
1236QLT announces third quarter financial results newswire.caAl Collard-10/24/2001
1235Julia estimates that about 50,000 to 60,000 new US patients will be included witIan@SI-10/19/2001
1234Julia Levy, CEO scheduled for an interview on CNBC at 3:45PM ET today... [eom]Ian@SI-10/19/2001
1233Visudyne(TM) therapy reimbursement in U.S. expanded to include patients with occAl Collard-10/19/2001
1232<b>QLT sales increase 86% in Q3; conference call Oct. 24 </b> Al Collard-10/11/2001
1231<b>QLT expects to meet annual financial targets </b> Al Collard-10/1/2001
1230NOVARTIS AG: QLT INC - Novartis Ophthalmics and QLT File Submission With the EurIan@SI-9/7/2001
1229informedinvestors.com Replay with slides now available...Ian@SI-8/28/2001
1228QLT drug gains approval for two more uses Successful FDA tesAndras-8/24/2001
1227August 23, 2001 QLT Sees New Visudyne Approval Boosting Market 40% By TAMSIIan@SI-8/23/2001
1226Thanks, Tuck. I missed this one. Regards, IanIan@SI-8/23/2001
1225This sucker ought to run a bit tomorrow: >>ATLANTA and VANCOUVER, Britishtuck-8/23/2001
1224QLT Has 2nd-Quarter Profit as Sales of Visudyne Drug Double By Theresa Ebden VaJulian-7/25/2001
1223July 13, 2001 QLT Up 11%; Market Optimistic For 2Q, Analyst Says By ANDYIan@SI-7/13/2001
1222That was what I was referring to. I suppose we will have to follow the earning Scripts-6/26/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News